Mar 2024 Detection of NPS in Buprenorphine Samples
Aegis recently conducted a retrospective analysis of patient samples from individuals who were prescribed buprenorphine to ascertain how frequently novel...
In Practice: Clinical Insights
Feb 2024 Medication Monitoring in Behavioral Health
Mental illness is common in the United States, with an estimated 52.9 million people – about 1 in 5 adults...
Jan 2024 BioDetect: Identifying Non-Urine Substances
Healthcare providers rely on medication adherence test results to assist in measuring compliance and evaluating recent substance use. Providers must...
Dec 2023 An Overview of Testing Capabilities to Identify Use of Marijuana (THC) and Other Natural Cannabinoids
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""] Following the passing of the 2018 Agriculture Improvement Act (a.k.a. Farm Bill),...
Nov 2023 Synthetic Stimulants
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
Oct 2023 Nitazene Analogs
Nitazene analogs are a subclass of designer opioids that are structurally different from opioids but attach to the same mu-opioid...
